Skip to content

Liposomal Bupivacaine vs Bupivacaine for Pain Control After Sternotomy

Liposomal Bupivacaine vs Bupivacaine for Pain Control After Sternotomy

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04585867
Enrollment
80
Registered
2020-10-14
Start date
2017-10-11
Completion date
2023-10-10
Last updated
2020-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain Management, Sternotomy

Brief summary

Researchers hope to learn whether giving the longer-acting local anesthetic liposomal bupivacaine prior to closing the sternum is more effective in managing pain following sternotomy, than in patients who received standard bupivacaine before sternal closure. Researchers will measure this based on how much IV pain medication is used, rates on confusion, and time to remove the breathing tube.

Interventions

DRUGExparel

The injections will be performed under direct guidance by the cardiac surgeon at bilateral sternal-costal interspaces 1.5 cm lateral the sternal boarder at levels 2-6 in divided doses (2 ml/injection) just before the closure of the sternum near the end of the surgical procedure. The final 20 ml will be injected into the skin incision after closure

DRUGBupivacaine

The injections will be performed under direct guidance by the cardiac surgeon at bilateral sternal-costal interspaces 1.5 cm lateral the sternal boarder at levels 2-6 in divided doses (2 ml/injection) just before the closure of the sternum near the end of the surgical procedure. The final 20 ml will be injected into the skin incision after closure

Sponsors

University of Kansas Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults over the age of 18 who present for elective open heart surgery that requires a sternotomy.

Exclusion criteria

* Urgent and emergency procedures, * preexisting sternal infections, * prior sternotomy, * preexisting pain syndromes, * current chronic home opioid use, * anterior rib or sternal masses, * allergy to any of the components of liposomal bupivacaine and plain bupivacaine.

Design outcomes

Primary

MeasureTime frameDescription
Opioid consumption in morphine equivalents0 hours post-surgeryOpioid consumption in morphine equivalents

Secondary

MeasureTime frameDescription
Time to extubation in minutes will be retrieved via the electronic medical record30 days post operativeTime to extubation in minutes will be retrieved via the electronic medical record
Presence of sternal wound infection4-6 weeks postoperative visitPresence of sternal wound infection will be retrieved via electronic medical record and at 30 day follow up for Society of Thoracic Surgery (STS) database data as well as sternal infection documented at standard postoperative visit at 4-6 weeks
Postoperative delirium as assessed by Confusion Assessment Method (CAM)-ICU30 days post operativePostoperative delirium as assessed by CAM-ICU at hours 0,12,24,36,48,60,and 72 hours post-surgery will be retrieved via the electronic medical record

Countries

United States

Contacts

Primary ContactAngie Ballew, DC, MS
aballew@kumc.edu9139457420

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026